Receptor-ligand interactions studied with homogeneous fluorescence-based assays suitable for miniaturized screening.
Cell membrane receptors play a central role in controlling cellular functions, making them the target of drugs for a wide variety of diseases. This report describes how a recently developed method, fluorescence intensity distribution analysis (FIDA), can be used to develop homogeneous, nonradioactive high throughput screening assays for membrane receptors. With FIDA, free ligand and ligand accumulated on receptor-bearing membrane vesicles can be distinguished on the basis of their particle brightness. This allows the concentration of both bound and free ligand to be determined reliably from a single measurement, without any separation. We demonstrate that ligand affinity, receptor expression level, and potency of inhibitors can be determined using the epidermal growth factor and beta(2)-adrenergic receptors as model systems. Highly focused confocal optics enable single-molecule sensitivity, and sample volumes can thus be reduced to 1 microl without affecting the quality of the fluorescence signal. Our results demonstrate that FIDA is an ideal method for membrane receptor assays offering substantial benefits for assay development and high throughput pharmaceutical screening.
Scheel
A A
AA
EVOTEC BioSystems AG, Hamburg, Germany. scheel@evotec.de
Funsch
B
B
Busch
M
M
Gradl
G
G
Pschorr
J
J
Lohse
M J
MJ
D066259:Betacellulin; D002460:Cell Line; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000706:statistics & numerical data; D004815:Epidermal Growth Factor / Q000378:metabolism; D066246:ErbB Receptors / Q000032:analysis / Q000378:metabolism; D005453:Fluorescence; D005456:Fluorescent Dyes; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D008904:Miniaturization; D055095:Optics and Photonics; D011412:Propanolamines / Q000378:metabolism; D011433:Propranolol / Q000378:metabolism; D018343:Receptors, Adrenergic, beta-2 / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000032:analysis / Q000378:metabolism*; D011994:Recombinant Proteins / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D012680:Sensitivity and Specificity
C587851:BTC protein, human; D066259:Betacellulin; D005456:Fluorescent Dyes; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D008024:Ligands; D011412:Propanolamines; D018343:Receptors, Adrenergic, beta-2; D011956:Receptors, Cell Surface; D011994:Recombinant Proteins; C026777:ICI 118551; D004815:Epidermal Growth Factor; D011433:Propranolol; D066246:ErbB Receptors; C033394:CGP 12177